New York, 8 Feb (ONA) ---- US pharmaceutical company Pfizer said that it had exceeded its goal of manufacturing 3 billion doses of Comirnaty, the Pfizer-BioNTech Covid-19 vaccine, in 2021. The company also increased its 2022 revenue guidance for Comirnaty, reflecting doses expected to be delivered under supply contracts signed as of late-January. Also, the company issued fiscal guidance for the coming year which, if achieved, would represent the highest level of annual revenues in its history. Pfizer also issued its long-term expectations for Covid-19. The company said the virus is ...